Skip to Main Content


Shore Capital Partners Announces Partnership with C2Dx and Acquisition of Otolaryngology/Head and Neck Surgery Assets from Cook Medical

January 24, 2024

CHICAGO & KALAMAZOO, Mich.–(BUSINESS WIRE)–Shore Capital Partners (“Shore” or “Shore Capital”) is pleased to announce it has completed a partnership with C2Dx (“C2Dx” or “The Company”), a medical device company based in Kalamazoo, Michigan, with a second location in Memphis, Tennessee. Following the partnership, Shore Capital and C2Dx are also pleased to announce they have

Intern Interview: Meet Piper

November 10, 2023

Piper Berg worked as a sales and marketing intern for C2Dx throughout the spring and summer of 2023. She’s a sales and marketing student at Western Michigan University, with expected graduation in 2024. During her time with C2Dx, Piper focused on T/Pump® business development in the veterinary space and lead engagement projects. Learn more about

Intern Interview: Meet Sofia

November 8, 2023

  Sofia Klein worked as a sales and marketing intern for C2Dx throughout the spring and summer of 2023. She’s a 2023 graduate from Kalamazoo College with marketing experience in the startup world. During her time with C2Dx, Sofia created informational, customer-centric content including an Acute Compartment Syndrome White Paper, and infographics outlining T/Pump Therapy

Medical Device Manufacturer C2Dx Onshores Production from Mexico to Michigan Facility

April 26, 2023

LANSING, Mich., April 20, 2022 /Michigan.Gov/ — Today, Governor Gretchen Whitmer joined the Michigan Economic Development Corporation (MEDC) to announce two business expansion projects expected to create a total of 65 new jobs and generate a total private investment of nearly $4 million have received support from the Michigan Strategic Fund. The projects are in Hudsonville and Schoolcraft.

Hemostatix, a local medical device company, acquired by Michigan-based C2Dx

March 15, 2022

About a year and a half ago, Hemostatix Medical Technologies, a Bartlett-based company, was in talks with a big medical device company regarding an acquisition. The larger, undisclosed company was interested in Hemostatix’s intellectual property — a unique thermal scalpel that seals blood vessels as they are incised, effectively enabling cutting and coagulating at the

C2Dx Announces the Acquisition of Hemostatix and its Thermal Scalpel System

March 9, 2022

KALAMAZOO, Mich., March 8, 2022 /PRNewswire/ — C2Dx, a privately held medical device company, announced its acquisition of Hemostatix Medical Technologies LLC (Hemostatix) effective on January 1, 2022. This latest expansion aligns with C2Dx’s strategy to invest in and refine the delivery of valuable niche products to propel their growth and accessibility worldwide. The acquisition

Kevin McLeod

2021 Newsmaker: Kevin McLeod

January 21, 2022

Kalamazoo-based medical device startup C2Dx was founded by Kevin McLeod and Ann Arbor-based growth capital firm Plymouth Growth in 2019 to invest in and refine the delivery of “valuable niche products” to propel its growth. And that’s exactly what happened in 2021. C2Dx’s second product acquisition occurred early last year when it purchased Stryker’s T/Pump

Business Journal selects Newsmaker finalists

December 16, 2021

The Grand Rapids Business Journal has selected the finalists for its 2021 Newsmaker of the Year awards. The 48 finalists in 16 categories will be celebrated on Jan. 26 during a breakfast event at Frederik Meijer Gardens and Sculpture Park. The Newsmaker show represents the first event in the Business Journal’s new Breakfast Series lineup,

1 2